The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bio-protein Drug Market Research Report 2024

Global Bio-protein Drug Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1712930

No of Pages : 100

Ask Your Query

Synopsis

Global Bio-protein Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bio-protein Drug market research.

Key manufacturers engaged in the Bio-protein Drug industry include Abbott Laboratories, Bayer AG, Eli Lilly and Company, Amgen Inc., Biocon Ltd., Dr. Reddy’s Laboratories, Roche, Fresenius kabi and GlaxoSmithKline, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Bio-protein Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Bio-protein Drug market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-protein Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Abbott Laboratories
  •     Bayer AG
  •     Eli Lilly and Company
  •     Amgen Inc.
  •     Biocon Ltd.
  •     Dr. Reddy’s Laboratories
  •     Roche
  •     Fresenius kabi
  •     GlaxoSmithKline
  •     Johnson & Johnson
  •     Merck
  •     Novartis AG
  •     Panacea Biotec
  •     ProBioGen AG
  •     Sanofi
  •     Reliance Life Science Pvt. Ltd.

Segment by Type

  •     Monoclonal Antibodies
  •     Therapeutic Proteins
  •     Vaccines

Segment by Application

  •     Pharma and Biotech Companies
  •     CROs
  •     Academics

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Bio-protein Drug report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

  1.1 Product Overview and Scope of Bio-protein Drug
    1.2 Bio-protein Drug Segment by Type
        1.2.1 Global Bio-protein Drug Market Value Comparison by Type (2023-2029)
        1.2.2 Monoclonal Antibodies
        1.2.3 Therapeutic Proteins
        1.2.4 Vaccines
    1.3 Bio-protein Drug Segment by Application
        1.3.1 Global Bio-protein Drug Market Value by Application: (2023-2029)
        1.3.2 Pharma and Biotech Companies
        1.3.3 CROs
        1.3.4 Academics
    1.4 Global Bio-protein Drug Market Size Estimates and Forecasts
        1.4.1 Global Bio-protein Drug Revenue 2018-2029
        1.4.2 Global Bio-protein Drug Sales 2018-2029
        1.4.3 Global Bio-protein Drug Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Bio-protein Drug Market Competition by Manufacturers
    2.1 Global Bio-protein Drug Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Bio-protein Drug Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Bio-protein Drug Average Price by Manufacturers (2018-2023)
    2.4 Global Bio-protein Drug Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Bio-protein Drug, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Bio-protein Drug, Product Type & Application
    2.7 Bio-protein Drug Market Competitive Situation and Trends
        2.7.1 Bio-protein Drug Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Bio-protein Drug Players Market Share by Revenue
        2.7.3 Global Bio-protein Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Bio-protein Drug Retrospective Market Scenario by Region
    3.1 Global Bio-protein Drug Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Bio-protein Drug Global Bio-protein Drug Sales by Region: 2018-2029
        3.2.1 Global Bio-protein Drug Sales by Region: 2018-2023
        3.2.2 Global Bio-protein Drug Sales by Region: 2024-2029
    3.3 Global Bio-protein Drug Global Bio-protein Drug Revenue by Region: 2018-2029
        3.3.1 Global Bio-protein Drug Revenue by Region: 2018-2023
        3.3.2 Global Bio-protein Drug Revenue by Region: 2024-2029
    3.4 North America Bio-protein Drug Market Facts & Figures by Country
        3.4.1 North America Bio-protein Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Bio-protein Drug Sales by Country (2018-2029)
        3.4.3 North America Bio-protein Drug Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Bio-protein Drug Market Facts & Figures by Country
        3.5.1 Europe Bio-protein Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Bio-protein Drug Sales by Country (2018-2029)
        3.5.3 Europe Bio-protein Drug Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Bio-protein Drug Market Facts & Figures by Country
        3.6.1 Asia Pacific Bio-protein Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Bio-protein Drug Sales by Country (2018-2029)
        3.6.3 Asia Pacific Bio-protein Drug Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Bio-protein Drug Market Facts & Figures by Country
        3.7.1 Latin America Bio-protein Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Bio-protein Drug Sales by Country (2018-2029)
        3.7.3 Latin America Bio-protein Drug Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Bio-protein Drug Market Facts & Figures by Country
        3.8.1 Middle East and Africa Bio-protein Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Bio-protein Drug Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Bio-protein Drug Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Bio-protein Drug Sales by Type (2018-2029)
        4.1.1 Global Bio-protein Drug Sales by Type (2018-2023)
        4.1.2 Global Bio-protein Drug Sales by Type (2024-2029)
        4.1.3 Global Bio-protein Drug Sales Market Share by Type (2018-2029)
    4.2 Global Bio-protein Drug Revenue by Type (2018-2029)
        4.2.1 Global Bio-protein Drug Revenue by Type (2018-2023)
        4.2.2 Global Bio-protein Drug Revenue by Type (2024-2029)
        4.2.3 Global Bio-protein Drug Revenue Market Share by Type (2018-2029)
    4.3 Global Bio-protein Drug Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Bio-protein Drug Sales by Application (2018-2029)
        5.1.1 Global Bio-protein Drug Sales by Application (2018-2023)
        5.1.2 Global Bio-protein Drug Sales by Application (2024-2029)
        5.1.3 Global Bio-protein Drug Sales Market Share by Application (2018-2029)
    5.2 Global Bio-protein Drug Revenue by Application (2018-2029)
        5.2.1 Global Bio-protein Drug Revenue by Application (2018-2023)
        5.2.2 Global Bio-protein Drug Revenue by Application (2024-2029)
        5.2.3 Global Bio-protein Drug Revenue Market Share by Application (2018-2029)
    5.3 Global Bio-protein Drug Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Abbott Laboratories
        6.1.1 Abbott Laboratories Corporation Information
        6.1.2 Abbott Laboratories Description and Business Overview
        6.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Abbott Laboratories Bio-protein Drug Product Portfolio
        6.1.5 Abbott Laboratories Recent Developments/Updates
    6.2 Bayer AG
        6.2.1 Bayer AG Corporation Information
        6.2.2 Bayer AG Description and Business Overview
        6.2.3 Bayer AG Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Bayer AG Bio-protein Drug Product Portfolio
        6.2.5 Bayer AG Recent Developments/Updates
    6.3 Eli Lilly and Company
        6.3.1 Eli Lilly and Company Corporation Information
        6.3.2 Eli Lilly and Company Description and Business Overview
        6.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Eli Lilly and Company Bio-protein Drug Product Portfolio
        6.3.5 Eli Lilly and Company Recent Developments/Updates
    6.4 Amgen Inc.
        6.4.1 Amgen Inc. Corporation Information
        6.4.2 Amgen Inc. Description and Business Overview
        6.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Amgen Inc. Bio-protein Drug Product Portfolio
        6.4.5 Amgen Inc. Recent Developments/Updates
    6.5 Biocon Ltd.
        6.5.1 Biocon Ltd. Corporation Information
        6.5.2 Biocon Ltd. Description and Business Overview
        6.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Biocon Ltd. Bio-protein Drug Product Portfolio
        6.5.5 Biocon Ltd. Recent Developments/Updates
    6.6 Dr. Reddy’s Laboratories
        6.6.1 Dr. Reddy’s Laboratories Corporation Information
        6.6.2 Dr. Reddy’s Laboratories Description and Business Overview
        6.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Dr. Reddy’s Laboratories Bio-protein Drug Product Portfolio
        6.6.5 Dr. Reddy’s Laboratories Recent Developments/Updates
    6.7 Roche
        6.6.1 Roche Corporation Information
        6.6.2 Roche Description and Business Overview
        6.6.3 Roche Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Roche Bio-protein Drug Product Portfolio
        6.7.5 Roche Recent Developments/Updates
    6.8 Fresenius kabi
        6.8.1 Fresenius kabi Corporation Information
        6.8.2 Fresenius kabi Description and Business Overview
        6.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Fresenius kabi Bio-protein Drug Product Portfolio
        6.8.5 Fresenius kabi Recent Developments/Updates
    6.9 GlaxoSmithKline
        6.9.1 GlaxoSmithKline Corporation Information
        6.9.2 GlaxoSmithKline Description and Business Overview
        6.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 GlaxoSmithKline Bio-protein Drug Product Portfolio
        6.9.5 GlaxoSmithKline Recent Developments/Updates
    6.10 Johnson & Johnson
        6.10.1 Johnson & Johnson Corporation Information
        6.10.2 Johnson & Johnson Description and Business Overview
        6.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Johnson & Johnson Bio-protein Drug Product Portfolio
        6.10.5 Johnson & Johnson Recent Developments/Updates
    6.11 Merck
        6.11.1 Merck Corporation Information
        6.11.2 Merck Bio-protein Drug Description and Business Overview
        6.11.3 Merck Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Merck Bio-protein Drug Product Portfolio
        6.11.5 Merck Recent Developments/Updates
    6.12 Novartis AG
        6.12.1 Novartis AG Corporation Information
        6.12.2 Novartis AG Bio-protein Drug Description and Business Overview
        6.12.3 Novartis AG Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Novartis AG Bio-protein Drug Product Portfolio
        6.12.5 Novartis AG Recent Developments/Updates
    6.13 Panacea Biotec
        6.13.1 Panacea Biotec Corporation Information
        6.13.2 Panacea Biotec Bio-protein Drug Description and Business Overview
        6.13.3 Panacea Biotec Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Panacea Biotec Bio-protein Drug Product Portfolio
        6.13.5 Panacea Biotec Recent Developments/Updates
    6.14 ProBioGen AG
        6.14.1 ProBioGen AG Corporation Information
        6.14.2 ProBioGen AG Bio-protein Drug Description and Business Overview
        6.14.3 ProBioGen AG Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.14.4 ProBioGen AG Bio-protein Drug Product Portfolio
        6.14.5 ProBioGen AG Recent Developments/Updates
    6.15 Sanofi
        6.15.1 Sanofi Corporation Information
        6.15.2 Sanofi Bio-protein Drug Description and Business Overview
        6.15.3 Sanofi Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.15.4 Sanofi Bio-protein Drug Product Portfolio
        6.15.5 Sanofi Recent Developments/Updates
    6.16 Reliance Life Science Pvt. Ltd.
        6.16.1 Reliance Life Science Pvt. Ltd. Corporation Information
        6.16.2 Reliance Life Science Pvt. Ltd. Bio-protein Drug Description and Business Overview
        6.16.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Revenue and Gross Margin (2018-2023)
        6.16.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Portfolio
        6.16.5 Reliance Life Science Pvt. Ltd. Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Bio-protein Drug Industry Chain Analysis
    7.2 Bio-protein Drug Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Bio-protein Drug Production Mode & Process
    7.4 Bio-protein Drug Sales and Marketing
        7.4.1 Bio-protein Drug Sales Channels
        7.4.2 Bio-protein Drug Distributors
    7.5 Bio-protein Drug Customers

 8 Bio-protein Drug Market Dynamics
    8.1 Bio-protein Drug Industry Trends
    8.2 Bio-protein Drug Market Drivers
    8.3 Bio-protein Drug Market Challenges
    8.4 Bio-protein Drug Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock